Purchase this article with an account.
Stefano Barabino, Elisa Montaldo, Elisabetta Corsi, Cristiana Valente, Federico Solignani, Maria Cristina Mingari, Maurizio Rolando; The Effect of Tapered Small Dose Steroidal Treatment on Symptoms, Clinical Signs, and Ocular Surface Inflammation in Patients with Dry Eye Syndrome. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3826.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To determine whether treatment with small tapered doses of steroid (loteprednolol etabonate) can reduce symptoms, signs and conjunctival epithelium expression of inflammatory markers in patients with dry eye syndrome (DES).
Twenty patients with DES have been enrolled for this double-masked, randomized, pilot study. Diagnosis of DES and treatment outcomes were assessed by means of OSDI questionnaire, Schirmer I test, tear break-up time (BUT), lissamine green conjunctival staining (NEI scoring system), fluorescein corneal staining, and HLA-DR expression on conjunctival cells. The enrolled patients were divided into 2 groups: study group (n=10) was treated with loteprednolol etabonate 0.5% b.i.d. for 14 days tapered at once a day for 15 days, and then every other day for 4 weeks. Control group underwent the same regimen with NaCl 0.9%. Best corrected visual acuity, intraocular pressure and evaluations were performed at day 0, day 14, and day 56.
A significant decrease of ocular surface inflammation and improvement of symptoms was recorded in the study group compared to controls at day 14 and 56. No significant difference was found for BUT and corneal fluorescein staining, but there was a consistent trend for improvement of lissamine green staining in the study group. None of the treated eyes showed significant increase in intraocular pressure or worsening of best corrected visual acuity.
Treatment with tapered doses of loteprednol etabonate 0.5% suspension seems to control ocular surface inflammation and damage, improving dry eye patient’s symptoms. Larger studies are necessary to confirm these preliminary results.
Clinical Trial: :
This PDF is available to Subscribers Only